Next webinar

Oct 17, 2024

1 PM (CET)

MS-Teams

scheduled

THREE

Webinar THREE is dedicated to pediatric case reports and Eleva’s CPV-104 study program.

Stay in the loop

Speakers

To be announced

More information soon

To be announced

More information soon

To be announced

More information soon

Stay in the loop

Subscribe to our next webinars

I consent to the processing of my personal data for the purpose of establishing contact in accordance with Article 6 paragraph 1 lit a of the Basic Data Protection Regulation (DSGVO). In accordance with Article 13 of the Basic Data Protection Regulation (DSGVO), we would like to provide you with comprehensive information about the processing of your personal data. You can read all relevant information in our data protection policy.

Thank you for your message. It has been sent.
There was an error trying to send your message. Please try again later.

Our webinar series offers firsthand insights from experts, scientists and clinicians about C3 Glomerulopathy (C3G) such as epidemiology, diagnosis, treatment, management and coping strategies. You will hear about all the relevant aspects, including Eleva’s initiatives to develop new treatment options for this ultrarare disease with high unmet medical need. Join the series for regular updates on Eleva’s clinical development efforts.

Stay in the loop

Next webinars

  • Oct 17, 2024

    ...is dedicated to pediatric case reports and Eleva’s Factor H (CPV-104) study program.
  • Dec 5, 2024

    ...will zoom in on spectrum 2 and provide more insight into Eleva’s technology.
You missed one of our editions?

Previous webinars

  • Dr. Andreas Busch / Dr. Fernando Caravaca-Fontán / Prof. Thorsten Wiech

    Jun 13, 2024

    recorded

  • Dr. Bjoern Cochlovius / Prof. Dr. Peter Zipfel / Prof. Dr. Dinesh Khullar

    Mar 14, 2024

    recorded

Back to